Spruce Biosciences Inc (SPRB)

Feb 06, 2026

Spruce Biosciences: TA-ERT’s Promising Long-Term Data and Priority Review Voucher Upside Underpin Reiterated Buy and $220 Target - TipRanks

Feb 06, 2026

Feb 05, 2026

Experimental enzyme therapy stabilizes skills for 6 years in fatal disorder - stocktitan.net

Feb 05, 2026

Feb 04, 2026

Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team - BioSpace

Feb 04, 2026

Feb 03, 2026

Spruce Biosciences Makes Two SVP Appointments - Contract Pharma

Feb 03, 2026

Feb 03, 2026

Spruce Biosciences (NASDAQ:SPRB) Shares Up 0.6%Time to Buy? - MarketBeat

Feb 03, 2026

Jan 29, 2026

Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™ - BioSpace

Jan 29, 2026

Jan 28, 2026

Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium - Investing News Network

Jan 28, 2026

Jan 21, 2026

Harbour BioMed Exercises Warrant to Acquire 3.8% of Spruce Biosciences Inc. - intellectia.ai

Jan 21, 2026

Jan 21, 2026

Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences - Benzinga

Jan 21, 2026

Jan 20, 2026

Harbour BioMed Acquires Stake in U.S. Partner Spruce Biosciences, Signaling Strategic Shift in Chinese Biotech - IndexBox

Jan 20, 2026

Jan 20, 2026

Harbour BioMed Acquires 3.8% of Spruce Biosciences, Enhancing Strategic Partnership - intellectia.ai

Jan 20, 2026

Jan 19, 2026

Harbour BioMed Expands Stake in Spruce Biosciences (SPRB) - GuruFocus

Jan 19, 2026

Jan 19, 2026

Harbour BioMed Exercises Agreement to Buy Spruce Biosciences Common Stock - Contract Pharma

Jan 19, 2026

Jan 18, 2026

Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences (SPRB) - Intellectia AI

Jan 18, 2026

Jan 18, 2026

Harbour BioMed Acquires 3.8% Stake in Spruce Biosciences - Intellectia AI

Jan 18, 2026

Jan 18, 2026

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deep - GuruFocus

Jan 18, 2026

Jan 18, 2026

Harbour BioMed Exercises Warrant To Acquire Stake In Spruce Biosciences - Nasdaq

Jan 18, 2026

Jan 18, 2026

HBM Holdings Deepens Ties With Spruce Biosciences via Warrant Exercise - TipRanks

Jan 18, 2026

Jan 18, 2026

Harbour BioMed buys into Spruce to back new hormone disorder drug - Stock Titan

Jan 18, 2026

Jan 18, 2026

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration - Barchart.com

Jan 18, 2026

Jan 18, 2026

Harbour BioMed takes stake in Spruce Biosciences - MSN

Jan 18, 2026

Jan 18, 2026

HBM Lifts Spruce Biosciences Stake to About 3.8% After Warrant Exercise - marketscreener.com

Jan 18, 2026

Jan 14, 2026

Spruce Biosciences (SPRB) Price Target Increased by 10.02% to 235.11 - Nasdaq

Jan 14, 2026

Jan 11, 2026

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 11, 2026

Jan 08, 2026

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital - BioSpace

Jan 08, 2026

Jan 08, 2026

Spruce Biosciences secures up to $50 million in growth capital from Avenue Capital - marketscreener.com

Jan 08, 2026

Jan 08, 2026

Spruce Biosciences Signs Multiple Financing Agreements - TradingView — Track All Markets

Jan 08, 2026

Jan 01, 2026

Spruce Biosciences (SPRB) price target increased by 55.76% to 213.69 - MSN

Jan 01, 2026

Dec 29, 2025

MSN Money - MSN

Dec 29, 2025

Dec 28, 2025

Spruce Biosciences assumed with a buy at HC Wainwright - MSN

Dec 28, 2025

Dec 27, 2025

Spruce Biosciences (NASDAQ:SPRB) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Dec 27, 2025

Dec 24, 2025

Equities Analysts Offer Predictions for SPRB FY2025 Earnings - MarketBeat

Dec 24, 2025

Dec 24, 2025

Spruce Biosciences initiated with an Outperform at Oppenheimer - Yahoo Finance

Dec 24, 2025

Dec 23, 2025

Oppenheimer Initiates Coverage on SPRB with "Outperform" Rating - GuruFocus

Dec 23, 2025

Dec 23, 2025

Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls - Yahoo Finance

Dec 23, 2025

Dec 23, 2025

Oppenheimer starts Spruce Biosciences with "outperform" rating on rare disease strength - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Oppenheimer initiates coverage on Spruce Biosciences stock with Outperform rating - Investing.com Australia

Dec 23, 2025

Dec 23, 2025

Oppenheimer Initiates Coverage of Spruce Biosciences (SPRB) with Outperform Recommendation - Nasdaq

Dec 23, 2025

Dec 23, 2025

Revenue per share of Spruce Biosciences, Inc. – NASDAQ:SPRB - TradingView — Track All Markets

Dec 23, 2025

Dec 22, 2025

Spruce Biosciences stock rating resumed at Buy by H.C. Wainwright - Investing.com Nigeria

Dec 22, 2025

Dec 22, 2025

HC Wainwright Reaffirms Buy Rating for Spruce Biosciences (NASDAQ:SPRB) - MarketBeat

Dec 22, 2025

Dec 22, 2025

SPRB Stock: HC Wainwright & Co. Initiates Coverage with Buy Rati - GuruFocus

Dec 22, 2025

Dec 21, 2025

Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to S&P TMI Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

With Spruce Biosciences Stock Sliding, Have You Assessed The Risk? - Trefis

Dec 20, 2025

Dec 17, 2025

[Form 4] SPRUCE BIOSCIENCES, INC. Insider Trading Activity - Stock Titan

Dec 17, 2025

Dec 17, 2025

Spruce Biosciences CEO reports RSU vesting and option repricing | SPRB SEC FilingForm 4 - Stock Titan

Dec 17, 2025

Dec 17, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 17, 2025

Dec 17, 2025

Spruce Biosciences Appoints Keli Walbert as Director - The Globe and Mail

Dec 17, 2025